As of Jun 23
| -2.03 / -1.50%|
The 23 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 130.00, with a high estimate of 153.00 and a low estimate of 85.00. The median estimate represents a -2.62% decrease from the last price of 133.50.
The current consensus among 27 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.